Epigenetics Drugs and Diagnostic Technologies Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Epigenetics Drugs and Diagnostic Technologies Market, By Product

7.1.  Epigenetics Drugs and Diagnostic Technologies Market, By Product, 2020-2028

7.1.1.    Reagents

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Kits

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Instruments

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Enzymes

7.1.4.1.        Market Revenue and Forecast (2016-2028)

7.1.5.    Services

7.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Epigenetics Drugs and Diagnostic Technologies Market, By Technology

8.1.  Epigenetics Drugs and Diagnostic Technologies Market, By Technology, 2020-2028

8.1.1.    DNA Methylation

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Histone Methylation

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Histone Acetylation

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Large Non-coding RNA

8.1.4.1.        Market Revenue and Forecast (2016-2028)

8.1.5.    MicroRNA Modification

8.1.5.1.        Market Revenue and Forecast (2016-2028)

8.1.6.    Chromatin Structures

8.1.6.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Epigenetics Drugs and Diagnostic Technologies Market, By Type of Therapy

9.1.  Epigenetics Drugs and Diagnostic Technologies Market, By Type of Therapy, 2020-2028

9.1.1.    Histone Deacetylase (HDAC) Inhibitors

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    DNA Methyltransferase (DNMT) Inhibitors

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Epigenetics Drugs and Diagnostic Technologies Market, By Capacitor

10.1.        Epigenetics Drugs and Diagnostic Technologies Market, by Capacitor, 2020-2028

10.1.1.  Oncology

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Non-oncology

10.1.2.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Epigenetics Drugs and Diagnostic Technologies Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Product (2016-2028)

11.1.2.  Market Revenue and Forecast, By Technology (2016-2028)

11.1.3.  Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.1.4.  Market Revenue and Forecast, by Capacitor (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Product (2016-2028)

11.1.5.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.5.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.1.5.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Product (2016-2028)

11.1.6.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.6.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.1.6.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Product (2016-2028)

11.2.2.  Market Revenue and Forecast, By Technology (2016-2028)

11.2.3.  Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.2.4.  Market Revenue and Forecast, by Capacitor (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Product (2016-2028)

11.2.5.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.5.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.2.5.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Product (2016-2028)

11.2.6.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.6.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.2.6.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Product (2016-2028)

11.2.7.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.7.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.2.7.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Product (2016-2028)

11.2.8.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.8.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.2.8.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Product (2016-2028)

11.3.2.  Market Revenue and Forecast, By Technology (2016-2028)

11.3.3.  Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.3.4.  Market Revenue and Forecast, by Capacitor (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Product (2016-2028)

11.3.5.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.5.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.3.5.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Product (2016-2028)

11.3.6.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.6.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.3.6.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Product (2016-2028)

11.3.7.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.7.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.3.7.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Product (2016-2028)

11.3.8.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.8.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.3.8.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Product (2016-2028)

11.4.2.  Market Revenue and Forecast, By Technology (2016-2028)

11.4.3.  Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.4.4.  Market Revenue and Forecast, by Capacitor (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Product (2016-2028)

11.4.5.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.5.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.4.5.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Product (2016-2028)

11.4.6.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.6.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.4.6.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Product (2016-2028)

11.4.7.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.7.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.4.7.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Product (2016-2028)

11.4.8.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.8.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.4.8.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Product (2016-2028)

11.5.2.  Market Revenue and Forecast, By Technology (2016-2028)

11.5.3.  Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.5.4.  Market Revenue and Forecast, by Capacitor (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Product (2016-2028)

11.5.5.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.5.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.5.5.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Product (2016-2028)

11.5.6.2.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.6.3.      Market Revenue and Forecast, By Type of Therapy (2016-2028)

11.5.6.4.      Market Revenue and Forecast, by Capacitor (2016-2028)

Chapter 12.  Company Profiles

12.1.              Roche Diagnostics

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Thermo Fisher Scientific, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Eisai Co. Ltd.

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Novartis AG

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Illumina, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Merck Sharp & Dohme Corp

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Qiagen

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Abcam PLC

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Merck KGaA

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms